Neurocrine Biosciences, Inc. - Common Stock

By Derek Hoffman Neurocrine Biosciences Inc. (NASDAQ:NBIX) will unveil its latest earnings on Wednesday, February 8, 2012. Neurocrine Biosciences discovers, develops, and commercializes drugs for the treatment of neurological and endocrine-related ...

SAN DIEGO, Feb. 2, 2012 /PRNewswire via COMTEX/ -- Neurocrine Biosciences, Inc. /quotes/zigman/55691/quotes/nls/nbix NBIX +1.33% announced today that the Company will report its fourth quarter and year-end 2011 financial results after the Nasdaq market ...

SAN DIEGO, Feb. 2, 2012 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company will report its fourth quarter and year-end 2011 financial results after the Nasdaq market closes on Wednesday, February 8, 2012.

Want to know the inside scoop? One of the best sources for what company insiders actually think about their companies is trends in insider buying.

There comes a time when it's best for everyone who is bullish to step back and take it easy for a while. It's never great to have markets only going in one direction, even if the move is on small candlesticks.